13-39655706-G-GC
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP6BS1
The NM_020751.3(COG6):c.-21_-20insC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000243 in 1,486,174 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00092 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00022 ( 1 hom. )
Consequence
COG6
NM_020751.3 5_prime_UTR
NM_020751.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -4.32
Genes affected
COG6 (HGNC:18621): (component of oligomeric golgi complex 6) This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi apparatus. The encoded protein is organized with conserved oligomeric Golgi complex components 5, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 13-39655706-G-GC is Benign according to our data. Variant chr13-39655706-G-GC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 312126.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000925 (51/55146) while in subpopulation EAS AF= 0.0069 (11/1594). AF 95% confidence interval is 0.00387. There are 0 homozygotes in gnomad4. There are 26 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COG6 | NM_020751.3 | c.-21_-20insC | 5_prime_UTR_variant | 1/19 | ENST00000455146.8 | ||
COG6 | NM_001145079.2 | c.-21_-20insC | 5_prime_UTR_variant | 1/19 | |||
COG6 | XM_011535168.2 | c.-21_-20insC | 5_prime_UTR_variant | 1/20 | |||
COG6 | NR_026745.1 | n.80_81insC | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COG6 | ENST00000455146.8 | c.-21_-20insC | 5_prime_UTR_variant | 1/19 | 1 | NM_020751.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000944 AC: 52AN: 55088Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
52
AN:
55088
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000586 AC: 35AN: 59716Hom.: 0 AF XY: 0.000490 AC XY: 16AN XY: 32622
GnomAD3 exomes
AF:
AC:
35
AN:
59716
Hom.:
AF XY:
AC XY:
16
AN XY:
32622
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000217 AC: 310AN: 1431028Hom.: 1 Cov.: 40 AF XY: 0.000231 AC XY: 164AN XY: 709170
GnomAD4 exome
AF:
AC:
310
AN:
1431028
Hom.:
Cov.:
40
AF XY:
AC XY:
164
AN XY:
709170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000925 AC: 51AN: 55146Hom.: 0 Cov.: 34 AF XY: 0.000977 AC XY: 26AN XY: 26600
GnomAD4 genome
AF:
AC:
51
AN:
55146
Hom.:
Cov.:
34
AF XY:
AC XY:
26
AN XY:
26600
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
2142
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 22, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
COG6-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 22, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at